Back to glossary

What is Preclinical Development?

What is Preclinical Development?

Preclinical development is the stage of research that occurs before clinical trials in humans, during feasibility, testing, and safety data are collected, typically through laboratory studies.

The main goals of preclinical development are:

  • To determine a safe starting dose for first-in-human studies

  • Assess potential toxicity of the product, which can include new drugs, devices, and diagnostics.

  • Develop a new drug scale up

  • Support the intended clinical trail

What is the difference between preclinical development and clinical development?

Preclinical DevelopmentClinical DevelopmentOccurs before testing in humansInvolves testing in human subjectsUses laboratory animals and in vitro studiesConducted in human clinical trialsAims to determine a safe starting dose and assess potential toxicityEvaluates efficacy and further assesses safety in patientsGenerates data for Investigational New Drug (IND) applicationGenerates data for New Drug Application (NDA) for marketing approvalAdheres to Good Laboratory Practices (GLPAdheres to Good Clinical Practices (GCP)Includes pharmacology, pharmacokinetics, and toxicology studiesDivided into phases (Phase 1, 2, 3, 4)Typically involves rodent and non-rodent animal modelsInvolves human subjects, often starting with healthy volunteers

Why is preclinical development important in pharma?

Preclinical development is essential for evaluating the safety and efficacy of drug candidates before human testing. It identifies potential adverse effects, determines safe dosages, and provides preliminary evidence for further testing. Regulatory agencies require comprehensive preclinical data to ensure safety for human trials, helping companies comply with legal standards. Early issue identification saves time and resources, avoiding costly failures in later phases. Additionally, preclinical data informs clinical trial design and strengthens intellectual property by supporting patents. In summary, preclinical development is vital for ensuring that safe and effective drug candidates reach the market.

Our Global Offices

We are where you need us to be. Connecting globally, delivering locally.

India

Melange Tower, 2nd Floor, Wing-C, Patrika Nagar, HITEC City, Madhapur, Hyderabad - 500081, Telangana, India

United States (Dallas)

17330 Preston Road Suite 200D, Dallas, TX, 75252

Canada (North York, Toronto)

5255 Yonge Street Suite 201, North York, ON, M2N 6P4

Australia (Melbourne)

Level 14, 330 Collins Street, Melbourne, VIC, 3000

South Korea (Daegu)

Daegu Trade Centre, 8/F. 489, Dongdaegu-ro, Daegu, 41256

Ireland (Dublin)

Block 1, Blanchardstown Corporate Park Ballycoolen Road, Dublin, D15 AKK1

Singapore

1 Scotts Road, #24-10 Shaw Centre, Singapore, Singapore, 228208

Stay Ahead in Life Sciences

Get the latest product updates, compliance news, and industry insights delivered to your inbox.